Valuation: H&R GmbH & Co. KGaA

Market Cap 227M 259M 211M 194M 365M 24.72B 371M 2.51B 982M 12.26B 971M 950M 42.35B P/E 2026 *
6.88x
P/E 2027 * 20.4x
Enterprise Value 250M 285M 233M 214M 401M 27.21B 408M 2.76B 1.08B 13.49B 1.07B 1.05B 46.62B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.18x
Free-Float
21.97%
Yield 2026 *
0.82%
Yield 2027 * 0.82%
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
26/03/25 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
26/03/25 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
1 day+0.82%
1 week-3.43%
Current month+24.75%
1 month+26.53%
3 months+35.67%
6 months+44.52%
Current year+44.52%
1 week 5.74
Extreme 5.74
6.6
1 month 4.91
Extreme 4.91
6.68
Current year 3.91
Extreme 3.91
6.68
1 year 3.91
Extreme 3.91
6.68
3 years 3.23
Extreme 3.23
6.68
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-3.43%+23.51%+17.87% 259M
-1.19%-2.98%+7.59%+27.01% 126B
-2.81%-4.48%-10.73%-42.36% 40.99B
-9.87%-27.62%+282.43%+102.72% 38.46B
+0.39%+3.82%+18.99%-22.17% 34.32B
+1.39%+3.06%+46.29%+62.77% 24.65B
+3.44%-3.55%-3.79%-39.20% 18.79B
+0.24%+10.08%+67.79%+227.71% 18.4B
-0.90%-5.07%+24.97%+373.92% 17.28B
+1.90%+6.52%+6.05%+8.25% 17B
Average -0.66%-5.01%+46.31%+71.65% 33.57B
Weighted average by Cap. -1.52%-4.89%+44.34%+49.01%

Financials

2026 *2027 *
Net sales 1.33B 1.52B 1.24B 1.14B 2.14B 145B 2.17B 14.7B 5.75B 71.83B 5.69B 5.57B 248B 1.33B 1.52B 1.24B 1.14B 2.14B 145B 2.18B 14.72B 5.76B 71.95B 5.7B 5.58B 249B
Net income 9.3M 10.6M 8.66M 7.97M 14.93M 1.01B 15.19M 103M 40.21M 502M 39.78M 38.92M 1.73B 11.3M 12.88M 10.52M 9.68M 18.14M 1.23B 18.45M 125M 48.86M 610M 48.34M 47.29M 2.11B
Net Debt 22.87M 26.06M 21.29M 19.59M 36.72M 2.49B 37.34M 253M 98.88M 1.23B 97.82M 95.71M 4.27B 8.65M 9.86M 8.06M 7.41M 13.89M 942M 14.13M 95.57M 37.41M 467M 37.01M 36.21M 1.61B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,692
Date Price Change Volume
29/07/26 6.120 +0.33% 39,327
28/07/26 €6.100 -5.86% 45,035
27/07/26 €6.480 +1.25% 55
24/07/26 €6.400 -2.14% 12,518
23/07/26 €6.540 +1.87% 19,390
Trader
Investor
Global
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.100EUR
Average target price
6.250EUR
Spread / Average Target
+2.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock